Evidence map›Paper›PMID 39716207›Full record

ArticleMicrobial cell factories2024

H

Tytti Jämsä, Nico J Claassens, Laura Salusjärvi, Antti Nyyssölä

Erratum issuedAbstract read
In one paragraph

Article in Microbial cell factories, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Hydrogen-driven, ATP-dependent biocatalytic reduction of carboxylic acids under non-explosive conditions.Green chemistry : an international journal and green chemistry resource : GC · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Tytti JämsäVTT Technical Research Centre of Finland Ltd., Tekniikantie 21, 02150, Espoo, Finland. tytti.jamsa@vtt.fi.ORCID http://orcid.org/0000-0002-7093-1869
Nico J ClaassensLaboratory of Microbiology, Wageningen University, Stippeneng 4, 6708WE, Wageningen, The Netherlands.ORCID http://orcid.org/0000-0003-1593-0377
Laura SalusjärviVTT Technical Research Centre of Finland Ltd., Tekniikantie 21, 02150, Espoo, Finland.ORCID http://orcid.org/0000-0002-2265-6778
Antti NyyssöläVTT Technical Research Centre of Finland Ltd., Tekniikantie 21, 02150, Espoo, Finland.ORCID http://orcid.org/0000-0002-8195-3967

Funding

Research Council of Finland 342124
6 · The paper itself

Abstract

backgroundBiocatalysis offers a potentially greener alternative to chemical processes. For biocatalytic systems requiring cofactor recycling, hydrogen emerges as an attractive reducing agent. Hydrogen is attractive because all the electrons can be fully transferred to the product, and it can be efficiently produced from water using renewable electricity. In this article, resting cells of Cupriavidus necator H16 harboring a NAD-dependent hydrogenase were employed for cofactor recycling to reduce D-xylose to xylitol, a commonly used sweetener. To enable this bioconversion, D-xylose reductase from Scheffersomyces stipitis was heterologously expressed in C. necator.

resultsD-xylose reductase was successfully expressed in C. necator, enabling almost complete bioconversion of 30 g/L of D-xylose into xylitol. It was found that over 90% of the energy and protons derived from hydrogen were spent for the bioconversion, demonstrating the efficiency of the system. The highest xylitol productivity reached was 0.7 g/L/h. Additionally, the same chassis efficiently produced L-arabitol and D-ribitol from L-arabinose and D-ribose, respectively.

conclusionsThis study highlights the efficient utilization of renewable hydrogen as a reducing agent to power cofactor recycling. Hydrogen-oxidizing bacteria, such as C. necator, can be promising hosts for performing hydrogen-driven biocatalysis.

Indexed as

Cupriavidus necatorHydrogenXylitolAldehyde ReductaseBiocatalysisXyloseAldehyde ReductaseHydrogenXylitolXyloseBiotransformationCofactor recyclingCofactor regenerationCupriavidus necatorHydrogen-oxidizing bacteriaRalstonia eutropha

Identifiers

PMID39716207
PMCPMC11665087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.